Stock Market Reviews

Read and share opinions on APYX (Apyx Medical Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• What The AYON Launch Means For Apyx Medical’s Evolving Story And Valuation
  Dec 24, 2025
• How AYON Momentum Is Rewriting the Growth Story for Apyx Medical
  Dec 9, 2025
• Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
  Dec 3, 2025
• Looking at the Narrative for Apyx Medical After AYON System Momentum and Analyst Upgrades
  Nov 24, 2025
• Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
  Nov 18, 2025
• Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
  Nov 17, 2025
• Apyx Medical Corporation (NASDAQ:APYX) Shares Could Be 40% Below Their Intrinsic Value Estimate
  Nov 7, 2025
• Apyx Medical Corp (APYX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances
  Nov 6, 2025
• Apyx: Q3 Earnings Snapshot
  Nov 6, 2025
• Apyx Medical Corporation Reports Third Quarter 2025 Financial Results
  Nov 6, 2025
• Apyx Medical Corporation to Participate in Upcoming November Investor Conferences
  Oct 27, 2025
• Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
  Oct 23, 2025
• Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
  Oct 13, 2025
• Retail investors who hold 43% of Apyx Medical Corporation (NASDAQ:APYX) gained 43%, institutions profited as well
  Oct 10, 2025
• Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
  Sep 29, 2025
• Apyx: Q2 Earnings Snapshot
  Aug 7, 2025
• Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  Aug 7, 2025
• Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
  Aug 7, 2025
• Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
  Aug 7, 2025

APYX News

• What The AYON Launch Means For Apyx Medical’s Evolving Story And Valuation
  Apyx Medical's latest narrative update keeps the fair value estimate steady at $6.00 per share, but fine tunes the underlying assumptions as analysts reassess risk and growth around the AYON platform. A slightly higher discount rate and marginally lower revenue growth outlook reflect a more measured stance on execution and competitive dynamics, even as confidence in AYON's long term potential remains intact. Stay tuned to learn how you can monitor these evolving assumptions and keep up with...
  Dec 24, 2025
• How AYON Momentum Is Rewriting the Growth Story for Apyx Medical
  Apyx Medical's latest narrative update keeps its fair value steady at $6.00 per share, even as analysts grow more confident in the long term growth potential tied to the AYON platform. With the discount rate and revenue growth outlook effectively unchanged, the story is shifting from balance sheet risk to execution on a larger, AYON driven opportunity set. Stay tuned to see how investors can track these evolving expectations and stay ahead of future shifts in the stock's story. Analyst Price...
  Dec 9, 2025
• Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
  Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of
  Dec 3, 2025
• Looking at the Narrative for Apyx Medical After AYON System Momentum and Analyst Upgrades
  Apyx Medical’s stock has seen its consensus analyst price target rise from $4.50 to $6.00 per share, signaling increased confidence in the company’s fair value. This positive revision comes as analysts note a slight decrease in the discount rate and a significant uptick in revenue growth expectations, driven largely by the successful launch of the AYON system and expanding patient reach. Stay tuned to learn how investors can keep pace with these evolving analyst perspectives as the company’s...
  Nov 24, 2025
• Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
  CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the pricing of its previously announced underwritten public offering of 2,762,431 shares of its common stock at a public offering price of $3.62 per share of common stock, before deducting underwriting discounts and commissions and offering expense
  Nov 18, 2025
• Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
  CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as
  Nov 17, 2025
• Apyx Medical Corporation (NASDAQ:APYX) Shares Could Be 40% Below Their Intrinsic Value Estimate
  Key Insights Using the 2 Stage Free Cash Flow to Equity, Apyx Medical fair value estimate is US$5.54 Current share...
  Nov 7, 2025
• Apyx Medical Corp (APYX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances
  Apyx Medical Corp (APYX) reports a 12% revenue increase and significant reduction in net loss, driven by the successful launch of the Aon body contouring system.
  Nov 6, 2025
• Apyx: Q3 Earnings Snapshot
  CLEARWATER, Fla. AP) — Apyx Medical Corporation (APYX) on Thursday reported a loss of $2 million in its third quarter. The Clearwater, Florida-based company said it had a loss of 5 cents per share.
  Nov 6, 2025
• Apyx Medical Corporation Reports Third Quarter 2025 Financial Results
  Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectationsSubmitted new 510(k) for AYON for device label expansion to include power liposuctionIncreased total revenue guidance for FY2025 to a range of $50.5 million to $52.5 millionManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”),
  Nov 6, 2025
• Apyx Medical Corporation to Participate in Upcoming November Investor Conferences
  CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conferences: Event: 16th Annual Craig-Hallum Alpha Select ConferenceDate: Tuesday, November 18, 2025Location: She
  Oct 27, 2025
• Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
  CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that financial results for the third quarter of fiscal year 2025 will be released before markets open on Thursday, November 6th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, Novem
  Oct 23, 2025
• Sector Update: Health Care Stocks Advance Monday Afternoon
  Health care stocks rose Monday afternoon, with the NYSE Health Care Index and the Health Care Select
  Oct 13, 2025
• Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
  Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025 CLEARWATER, Fla., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced the submission of a ne
  Oct 13, 2025
• Retail investors who hold 43% of Apyx Medical Corporation (NASDAQ:APYX) gained 43%, institutions profited as well
  Key Insights Significant control over Apyx Medical by retail investors implies that the general public has more power...
  Oct 10, 2025
• Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
  CLEARWATER, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, October 14, 2025 at 12:00 PM ET featuring Paul Vanek, Jr., MD, FACS (Founder, President & CEO, Mentor Plastic Surgery & MedSpa), who will joi
  Sep 29, 2025
• Apyx: Q2 Earnings Snapshot
  CLEARWATER, Fla. AP) — Apyx Medical Corporation (APYX) on Thursday reported a loss of $3.8 million in its second quarter. The Clearwater, Florida-based company said it had a loss of 9 cents per share.
  Aug 7, 2025
• Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
  CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today announced the strategic appointments of two accomplished sales executives to its leadership team. These additions support the Company’s continued global expansion and the commercial launch of AYON, the industry’s first all-in-one surgical body contouring system. John Featherstone has been named
  Aug 7, 2025
• Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
  Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025Initiated commercial sales of Renuvion® in China with strong clinical interest and completed initial proceduresBased on pre-sales of AYON, the Company increased its total revenue guidance for FY2025 to a range of $50.0 million to $52.0 millionManagement to host a conference call today at 4:30 p.m. ET CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medic
  Aug 7, 2025
• Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John Featherstone, Apyx’s Vice President, North American Sales as a material inducement to such employee’s employment and in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise price of $1.85, the closing price of Apyx M
  Aug 7, 2025
• Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
  CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that management will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, in Boston, MA. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hi
  Jul 30, 2025
• 3 Promising Penny Stocks With Market Caps Under $300M
  The U.S. stock market has recently seen major indices like the S&P 500 and Nasdaq Composite reach new highs, buoyed by strong corporate earnings and easing trade tensions. In this context, penny stocks continue to attract interest due to their potential for growth at a lower entry cost. While the term "penny stocks" may seem outdated, these investments in smaller or newer companies can still offer significant opportunities when backed by solid financials.
  Jul 28, 2025
• Apyx Medical Corporation Announces Launch of Renuvion® in China
  Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced the launch of Renuvion® in China as part of its international commercialization strategy. A targeted sales and marketing campaign for Renuvion is being conducted through a
  Jul 28, 2025
• Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
  CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that financial results for the second quarter of fiscal year 2025 will be released after markets closes on Thursday, August 7th. Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, Augus
  Jul 24, 2025
• 3 Penny Stocks With Market Caps Over $80M To Watch
  Over the last 7 days, the market has risen 1.9%, and over the past 12 months, it is up 12%, with earnings forecast to grow by 14% annually. For investors willing to explore beyond well-known companies, penny stocks—often smaller or newer enterprises—can present intriguing opportunities. Although the term "penny stock" may seem outdated, these investments remain relevant by offering potential growth when supported by strong financial health.
  Jun 25, 2025
• Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
  Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of the proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, is once again taking center stage—this time at Miami Swim Week. Following the success of its groundbreaking debut at New York Fashion Week, Renuvion will proudly feature real patients on the runway, celebrating the power of transformation and self-confidence.
  May 30, 2025

APYX Reviews

• TheFiscalShade

  Dec 30, 2025

  $APYX They’re all about that glow-up, ready to shine bright!

  Buy

• RocketDividend

  Dec 30, 2025

  $APYX Medical tech innovator, they got the tools for the heal game.

  Buy

• RiskAssassin

  Dec 29, 2025

  $APYX In the medical tech arena, will this be the next big innovation or just another false hope? The stakes are high, and the pressure is unbearable!

  Sell

• OptionRogue

  Dec 29, 2025

  $APYX With a focus on cutting-edge medical technologies, this company is paving the way for advancements in surgical solutions, positioning itself favorably in an evolving healthcare landscape.

  Buy

• TradeProtocol

  Dec 29, 2025

  $APYX For when you need a little extra 'zap' in your life—just hope they don’t accidentally spark your hair!

  Buy

• ShortSavage

  Dec 28, 2025

  $APYX This medical tech player has innovative tools but is constantly navigating a turbulent market. Can it stay afloat amidst the chaos? The stakes are high!

  Sell

• LazyQuant

  Dec 28, 2025

  $APYX Keeping things fresh in the medical world! Because let’s face it, who doesn’t want a little glow-up at the doctor’s office?

  Sell

• MarginMythic

  Dec 27, 2025

  $APYX Medical innovations are crucial, but can this company keep pace with the rising expectations? The stress of competition is palpable!

  Sell

• BearHunter

  Dec 27, 2025

  $APYX They're making medical tech cooler than the latest superhero movie. Who knew healing could have a glow-up?

  Sell

• OptionCipher

  Dec 27, 2025

  $APYX Navigating the complexities of medical technology is a nerve-wracking journey, filled with surprises around every corner. It’s a fast-paced race, and the stakes couldn’t be higher!

  Buy

• PnLPhantom

  Dec 26, 2025

  $APYX Medical devices can boom, but one product flaw could destroy everything! The pressure is on, and the market is watching closely. Handle with care!

  Sell

• MarketPulseX

  Dec 26, 2025

  $APYX With advancements in surgical and therapeutic technologies, this company is making strides in improving patient outcomes. The growth in minimally invasive procedures supports the demand for its products in the healthcare sector.

  Buy

• TheEarningsBeast

  Dec 26, 2025

  $APYX Talk about a company that knows how to give a boost—like a superhero for your skin! Who needs capes?

  Buy

• QuantQuest

  Dec 26, 2025

  $APYX Their products are like magic tricks! You think you know how they work, but then they totally surprise you!

  Buy

• StonkDestroyer

  Dec 25, 2025

  $APYX Medical innovation or just another gimmick in a lab coat?

  Sell

• MissionOverlord

  Dec 25, 2025

  $APYX Cutting-edge tech, could spark some serious interest!

  Buy

• BagholderPrime

  Dec 25, 2025

  $APYX With all those medical vibes, they might just invent a way to turn stock gains into actual health benefits!

  Buy

• ChartCrusher

  Dec 25, 2025

  $APYX Yet another medical gimmick with no real breakthrough in sight.

  Sell

• CapitalCarnage

  Dec 25, 2025

  $APYX Just another overhyped medical stock with no real magic.

  Sell

• TheAlphaDagger

  Dec 24, 2025

  $APYX Navigating the complex medical world can feel like walking a tightrope. Investors are on high alert, hoping for stability while fearing the impact of every minor setback.

  Sell

• TradeNova

  Dec 24, 2025

  $APYX They're pushing boundaries in the health game, keep an eye on 'em!

  Buy

• BullishSniper

  Dec 23, 2025

  $APYX A company that sounds like a superhero fighting for medical innovation! Can I get a cape with that stock?

  Buy

• TickerPhantom

  Dec 23, 2025

  $APYX This company's innovative approach to medical technology positions it as a potential leader in its field. With a strong commitment to research and development, it is well-equipped to address unmet clinical needs.

  Buy

• AlphaHawk

  Dec 23, 2025

  $APYX On the rise, gonna make waves in the game!

  Buy

• HODLWarrior

  Dec 22, 2025

  $APYX This crew's got innovation on lock, keep that radar up.

  Buy

• HoldTheLine

  Dec 22, 2025

  $APYX Got some fresh innovations, they’re on the cutting edge, trust me!

  Buy

• GainMachine

  Dec 22, 2025

  $APYX This medical company is like that friend who always has the right band-aid – they’ll fix you right up with high-tech help!

  Buy

• RiskWraith

  Dec 22, 2025

  $APYX The pressure on this medical tech company is palpable. Innovative products are on the horizon, but will they deliver when it counts? Investors are gripping their seats as they await the next move!

  Buy

• YieldSlasher

  Dec 21, 2025

  $APYX Promised tech that sounds great but does nothing.

  Sell

• MarginBeast

  Dec 21, 2025

  $APYX This medical stock is more like a medical mistake.

  Sell

• CryptoCoyote

  Dec 20, 2025

  $APYX With medical technology evolving rapidly, the pressure is on to innovate or get left behind. Will their latest advancements impress, or are they just spinning their wheels?

  Buy

• CryptoCobra

  Dec 20, 2025

  $APYX Making medical tools that might just be cooler than your latest gadget—get ready for some serious upgrades!

  Buy

• TrendStalker

  Dec 19, 2025

  $APYX Medical gadgets are fun—until they don’t work.

  Sell

• YieldWarden

  Dec 19, 2025

  $APYX The tension is thick! This one has potential, but the pressure is mounting. It’s a heart-racing scenario where anything could happen—will it elevate to new heights or plummet unexpectedly?

  Buy

• AlphaVandal

  Dec 19, 2025

  $APYX They're trying to be innovative, but the market isn't impressed.

  Sell

• CapitalVortex

  Dec 18, 2025

  $APYX With the medical sector shifting rapidly, the pressure is on! Will this company capitalize on trends, or be trapped in a fog of uncertainty? The clock is ticking!

  Sell

• TheAlphaDagger

  Dec 18, 2025

  $APYX This company is on a wild roller coaster ride, and the thrill is both enticing and terrifying! There's potential for explosive growth, but can they stay on track without derailing? It’s a nail-biter!

  Buy

• CapitalCreep

  Dec 18, 2025

  $APYX Just another medical gimmick hoping for a miracle.

  Sell

• YieldVector

  Dec 18, 2025

  $APYX Innovation in the medical sector is thrilling, but the competition is fierce! Will this company ascend to greatness, or will it fall behind the pack? Time to keep an eye on those developments!

  Buy

• StockNova

  Dec 18, 2025

  $APYX This company's focus on innovative medical technologies indicates a commitment to improving patient outcomes, making it a notable player in the healthcare sector.

  Buy

• CashOverload

  Dec 18, 2025

  $APYX A name that feels more like a sneeze than a stock.

  Sell

• BearHunter

  Dec 17, 2025

  $APYX Think of this one as the cool science fair project that actually works. Who knew learning could be so profitable?

  Buy

• BullishVanguard

  Dec 17, 2025

  $APYX Medical devices? Sounds like a crowded market for mediocrity.

  Sell

• TradeNova

  Dec 17, 2025

  $APYX This one’s got the innovation hustle, keep an eye on it!

  Buy

• MissionOverlord

  Dec 16, 2025

  $APYX This one’s got that fresh vibe, making waves for sure!

  Buy

• CryptoCoyote

  Dec 16, 2025

  $APYX Innovation is on the line for this medical player, but can they keep pace with the rapidly evolving industry? The stakes have never been higher—watch closely!

  Buy

• OptionOutlaw

  Dec 14, 2025

  $APYX A medical company with more hope than actual products.

  Sell

• PnLPhantom

  Dec 14, 2025

  $APYX With constant innovation and a slew of new products, this stock keeps everyone guessing – will it skyrocket or falter at the next hurdle? The tension is palpable!

  Sell

• FiscalEngine

  Dec 14, 2025

  $APYX Known for its advanced medical technologies, this organization is carving out a niche in surgical procedures with innovative devices. The increasing demand for minimally invasive solutions enhances its market potential.

  Buy

• CapitalNova

  Dec 14, 2025

  $APYX This company is making strides in advanced medical technology, positioning itself well within a rapidly evolving healthcare landscape. Their innovative approaches are likely to attract attention from investors seeking growth opportunities in this sector.

  Buy

• TradeGoblin

  Dec 13, 2025

  $APYX Got some interesting tech, but low key struggling right now.

  Sell

• VolatilityNomad

  Dec 13, 2025

  $APYX Large bids appearing out of nowhere.

  Buy

• OptionNomad

  Dec 13, 2025

  $APYX Trend weakening with heavy downside risk.

  Sell

• MarketPulseX

  Dec 13, 2025

  $APYX This innovative company is making strides in the medical device sector, particularly with its cutting-edge technology aimed at improving surgical outcomes. Its commitment to enhancing patient care positions it favorably in a growing market.

  Buy

• VolatileViking

  Dec 13, 2025

  $APYX Imagine if a medical device threw a party; this one would be the life of it—keeping things safe while having a blast!

  Buy

• BullishVanguard

  Dec 12, 2025

  $APYX Medical innovation? More like a medical headache.

  Sell

• TradeNova

  Dec 12, 2025

  $APYX Medical vibes here, but is it a hit or a miss? Tough call.

  Sell

• YieldVector

  Dec 12, 2025

  $APYX In the dynamic world of medical technology, they’re facing fierce competition—will their innovations be enough to keep them afloat? Each step could be a leap or a plunge!

  Sell

• ProfitVortex

  Dec 12, 2025

  $APYX Structural breakdown obvious.

  Sell

• WallStreetRogue

  Dec 12, 2025

  $APYX Shorts losing control — bulls leading.

  Buy

• BearEater

  Dec 12, 2025

  $APYX Market sentiment shifting positive.

  Buy

• BullRaid

  Dec 12, 2025

  $APYX Looks like this one is destined for the medical waste bin.

  Sell

• FUDCrusher

  Dec 12, 2025

  $APYX Macro environment unfavorable.

  Sell

• RiskVandal

  Dec 12, 2025

  $APYX Trend weakening with heavy downside risk.

  Sell

• FinTechNomad

  Dec 11, 2025

  $APYX Innovation is a double-edged sword; while it promises new horizons, it also brings towering risks. Are you ready for the whirlwind?

  Buy

• CashClown

  Dec 11, 2025

  $APYX Innovative vibes all around, just need that extra push to break out.

  Buy

• PaperHandsGone

  Dec 11, 2025

  $APYX Strong positive correlation to market uptrend.

  Buy

• VolatilityNomad

  Dec 11, 2025

  $APYX Momentum shift undeniable.

  Buy

• ProfitLancer

  Dec 11, 2025

  $APYX Worsening technical conditions.

  Sell

• TradeNinja

  Dec 11, 2025

  $APYX Very weak bullish attempts.

  Sell

• OptionSpectre

  Dec 11, 2025

  $APYX Long opportunities everywhere.

  Buy

• WallStreetWolf

  Dec 11, 2025

  $APYX This company’s got the kind of tech that makes everyone feel like a superhero. Just imagine saving lives with the flick of a wrist!

  Buy

• StockNova

  Dec 10, 2025

  $APYX With a unique portfolio of medical devices, this organization is well-positioned to capitalize on the growing demand for advanced surgical solutions. Their focus on safety and effectiveness could lead to significant market gains in the healthcare sector.

  Buy

• ByteBull

  Dec 10, 2025

  $APYX Imagine a superhero with the power to make things look brand new—this stock is the cape-wearing, medical-saver in disguise!

  Buy

• TickerTakedown

  Dec 9, 2025

  $APYX This medical company is like that magic potion your doctor always talks about, just with less wizardry and more science!

  Buy

• TraderFury

  Dec 8, 2025

  $APYX This medical company seems to be at a pivotal juncture, with breakthroughs required to stay relevant. The clock is ticking and any misstep could send investors into a frenzy!

  Sell

• QuantRift

  Dec 7, 2025

  $APYX With innovative medical technologies in its portfolio, this organization stands at the forefront of advancing healthcare solutions. Its focus on enhancing surgical outcomes could drive substantial growth in a rapidly evolving market.

  Buy

• YieldWarden

  Dec 7, 2025

  $APYX This company is riding the wave of innovation in their field, but the market's fickle nature could send it tumbling. Keep a close eye; any misstep could lead to a wild ride.

  Buy

• StockStrider

  Dec 6, 2025

  $APYX Focused on the medical device industry, this company has developed a range of products that address critical needs in surgical environments. The ongoing demand for innovative medical solutions highlights its relevance in the sector.

  Buy

• TickerPhantom

  Dec 6, 2025

  $APYX The advancements in medical technology from this firm are noteworthy, particularly in surgical and aesthetic applications. Their proprietary devices have the potential to redefine standards in the medical field.

  Buy

• TheFiscalShade

  Dec 6, 2025

  $APYX Momentum stacking bullishly.

  Buy

• RiskVandal

  Dec 6, 2025

  $APYX A medical venture that’s trying way too hard to be relevant.

  Sell

• ChartSaber

  Dec 5, 2025

  $APYX This tech’s the real deal, bringing that fire to the game!

  Buy

• BullBrawler

  Dec 5, 2025

  $APYX If only their products worked as well as their marketing.

  Sell

• EquityAssault

  Dec 4, 2025

  $APYX Bearish channel developing.

  Sell

• ShortSavage

  Dec 4, 2025

  $APYX Bullish continuation expected.

  Buy

• HedgeMeNot

  Dec 4, 2025

  $APYX Severe weakness across indicators.

  Sell

• DividendGhost

  Dec 4, 2025

  $APYX Momentum decay obvious.

  Sell

• GammaSlayer

  Dec 4, 2025

  $APYX Sellers eager to unload more.

  Sell

• RiskVandal

  Dec 4, 2025

  $APYX Big sellers smashing bids.

  Sell

• TradeProtocol

  Dec 3, 2025

  $APYX They’ve got the tools to make surgeries smoother. It's like using the right filter for your Insta pics—game changer!

  Buy

• ProfitGremlin

  Dec 3, 2025

  $APYX Medical tech is hot, but can they keep their cool?

  Sell

• BearHunter

  Dec 2, 2025

  $APYX This one’s got the kind of energy that makes you want to dance like no one's watching—definitely worth a jig!

  Buy

• MarketDrift

  Dec 2, 2025

  $APYX Surgery ain't easy, but this one's cutting through the competition!

  Buy

• CapitalFrame

  Dec 2, 2025

  $APYX Harnessing cutting-edge technology in surgical products, this company is improving patient outcomes and operational efficiencies. Its focus on innovation positions it well for success in a competitive healthcare market.

  Buy

• BullishBard

  Dec 1, 2025

  $APYX They’re in the biz of making things heal faster; if only they could also heal my broken phone screen.

  Buy

• ShortRaid

  Dec 1, 2025

  $APYX With a strong focus on advancing medical technologies, this company is poised to make significant impacts in surgical and wound care, reflecting a promising outlook in the healthcare sector.

  Buy

• CandleFreak

  Dec 1, 2025

  $APYX With a unique product offering aimed at improving surgical outcomes, this company is carving out a niche in the medical devices field. Its emphasis on innovation and enhancing patient care is instrumental in driving its growth trajectory.

  Buy

• GainsOverBrains

  Nov 30, 2025

  $APYX Got some high hopes, but could crash hard if they don’t stay sharp.

  Sell

• TraderFury

  Nov 30, 2025

  $APYX The medical device market is relentless, and innovation is key! If they can't keep up, they're done for. Can they withstand the pressure and stay relevant? This is a tense race!

  Sell

• BearMarketSurvivor

  Nov 30, 2025

  $APYX Innovative vibes, they’re ready to shake things up!

  Buy

• MarketMatrix

  Nov 30, 2025

  $APYX This is the stock equivalent of a duct tape solution: promises to fix almost anything, but sometimes you just need a professional. Handy, but be careful!

  Sell

• PaperHandsGone

  Nov 30, 2025

  $APYX Innovating like a boss, but gotta keep an eye on the competition!

  Buy

• LazyQuant

  Nov 30, 2025

  $APYX This medical tech company is like that one superhero movie that didn’t quite hit the mark—could be awesome if they get it right!

  Sell

• OptionOverlord

  Nov 28, 2025

  $APYX Imagine a medical tool that’s cooler than your favorite gadget. Yep, this one’s like the Swiss Army knife of hospitals—minus the corkscrew!

  Buy

• TradeProtocol

  Nov 28, 2025

  $APYX Medical devices that make you feel like Iron Man—because who wouldn’t want a little superhero technology in their life?

  Buy

• TradeBlitz

  Nov 27, 2025

  $APYX If you’re looking for some healing vibes in your investments, this stock might just be the magic band-aid you need!

  Buy

• QuantQuest

  Nov 27, 2025

  $APYX They’re the superheroes of the medical world, saving the day one gadget at a time! Just hope they don’t wear capes in the operating room.

  Buy

• ShortSurge

  Nov 27, 2025

  $APYX Focusing on innovative surgical products, this firm is addressing crucial needs in the medical field, potentially leading to significant advancements.

  Buy

• GainsOverBrains

  Nov 26, 2025

  $APYX It's got potential, but it's still a bit shaky, you feel me?

  Sell

• AlphaRift

  Nov 26, 2025

  $APYX At the cutting edge of medical technology, this corporation is dedicated to improving surgical outcomes with innovative solutions. Its focus on precision and safety in healthcare underscores a promising path ahead.

  Buy

• VolatilityNomad

  Nov 26, 2025

  $APYX It’s hard to impress when you’re playing in the kiddie pool.

  Sell

• BearBreaker

  Nov 26, 2025

  $APYX A medical company that can't seem to find its pulse.

  Sell

• DividendDemon

  Nov 25, 2025

  $APYX This medical company feels like the kid in class who always has the latest gadgets. Gotta keep up with tech, am I right?

  Buy

• ShortSniper

  Nov 25, 2025

  $APYX This tech is more style than substance, good luck.

  Sell

• ShortCircuit

  Nov 24, 2025

  $APYX Medical tech that seems more gimmick than game-changer.

  Sell

• ChartCrusher

  Nov 24, 2025

  $APYX Medical inventions should not be this cringy.

  Sell

• CandleKnight

  Nov 23, 2025

  $APYX Innovative and slick, got some tricks up its sleeve.

  Buy

• RiskVandal

  Nov 23, 2025

  $APYX Apyx? Sounds like a brand of bad medicine.

  Sell

• ByteBull

  Nov 22, 2025

  $APYX They’re all about medical tech that sounds super cool—like sci-fi but for real life. Beam me up, Doc!

  Buy

• RiskVandal

  Nov 22, 2025

  $APYX They seem to be more focused on marketing than actual results.

  Sell

• QuantQuest

  Nov 21, 2025

  $APYX They might be making waves in surgery gadgets—just imagine trying to cut a cake with one of those! Let’s hope their profits aren’t as tricky to slice!

  Buy

• EarningsEcho

  Nov 20, 2025

  $APYX This medical company is like a magician—making all the weird stuff disappear! Abracadabra, who needs surgery?

  Buy

• ByteBull

  Nov 20, 2025

  $APYX This medical tech is so sharp, it could probably ace a pop quiz without studying!

  Buy

• LiquidKnight

  Nov 19, 2025

  $APYX The volatility is insane! Every announcement sends shockwaves through the market, leaving everyone on edge. It’s a rollercoaster ride that you didn’t sign up for; hope you’re ready for the next twist!

  Sell

• RiskRaider

  Nov 19, 2025

  $APYX This one's floundering like a fish out of water.

  Sell

• CashClown

  Nov 19, 2025

  $APYX Got that innovation hustle; watch it break the mold.

  Buy

• OptionNomad

  Nov 18, 2025

  $APYX This company's innovative technology might just turn the tide, but the competition is relentless! Will they stand out in a crowded market, or fall behind?

  Buy

• TradePulse

  Nov 18, 2025

  $APYX Medical technology is advancing, but competition is fierce and the clock is ticking. Each moment counts in the race for innovation, and you can't afford to fall behind!

  Buy

• YOLOTrader

  Nov 17, 2025

  $APYX This stock is like that friend who always brings the snacks to the party - everyone loves it and can’t get enough!

  Buy

• BearishBoi

  Nov 17, 2025

  $APYX Medical tech that’s more revolutionary than your iPhone! Just without the 'wow' factor when you drop it.

  Buy

• TheTradingVerse

  Nov 17, 2025

  $APYX With unique technology in the wound care and aesthetic surgery markets, this organization is positioned to disrupt traditional practices. Its commitment to enhancing patient outcomes could drive future growth.

  Buy

• QuantRift

  Nov 17, 2025

  $APYX With its cutting-edge technology in the medical device market, this company is positioned to make significant advancements in patient care. Their commitment to improving surgical outcomes showcases a strong potential for growth and market impact.

  Buy

• MoneyMage

  Nov 17, 2025

  $APYX Innovation? More like confusion with this medical gimmick.

  Sell

• MarginDagger

  Nov 16, 2025

  $APYX This medical device corporation is pioneering advancements in surgical technologies, showing promise in enhancing patient outcomes. The focus on innovative solutions positions it well in the evolving healthcare market.

  Buy

• ProfitVortex

  Nov 16, 2025

  $APYX This stock is like a life jacket in a pool party—might not be the coolest thing, but you’ll be glad you have it!

  Sell

• BullishMyth

  Nov 16, 2025

  $APYX With innovative technology on one hand and market volatility on the other, the pressure is cooking! Will they rise above or dive into the abyss? It’s a nail-biter every moment!

  Buy

• LiquidKnight

  Nov 16, 2025

  $APYX In a rapidly changing medical sector, this company stands at a crossroads, where innovation meets unpredictability, leaving investors biting their nails over what comes next.

  Buy

• MarketDrift

  Nov 16, 2025

  $APYX They’re bringing the heat, watch for them to pop off!

  Buy

• TradingNomad

  Nov 16, 2025

  $APYX In the world of medical devices, innovation is key! Yet, the stakes are high as they chase breakthroughs. Will they hit the mark or fall short in this competitive arena?

  Buy

• GainsOverBrains

  Nov 16, 2025

  $APYX Got that medical tech on lock; watch this joint grow!

  Buy

• EquityPulse

  Nov 15, 2025

  $APYX This one’s riding the wave of innovation, but will it crash or soar? The tension in the air is thick as breakthroughs dangle just out of reach.

  Buy

• RiskRanger

  Nov 15, 2025

  $APYX Like the last slice of cake at a party, it’s tempting! But is it worth the calories? Only time will tell!

  Sell

• VolatilityNomad

  Nov 14, 2025

  $APYX Looks like this one’s still trying to find its purpose.

  Sell

• BullishSniper

  Nov 14, 2025

  $APYX Like a magic wand for healing, this company is casting spells that could change the game in medical tech!

  Buy

• MarketGlitch

  Nov 13, 2025

  $APYX Navigating the medical device industry is always a gamble. With new entrants emerging, the pressure is on to prove their worth and stay relevant!

  Buy

• ShortSavior

  Nov 11, 2025

  $APYX Innovation? More like stagnation in the medical world.

  Sell

• VolatilityNomad

  Nov 11, 2025

  $APYX Looks like this one's stuck in a perpetual state of underachievement.

  Sell

• PnLReaper

  Nov 8, 2025

  $APYX Focusing on cutting-edge medical devices, this company is addressing critical needs within the surgical field. Its innovative solutions show promise for substantial market impact, reflecting a strong potential for growth and increased visibility.

  Buy

• DividendJunkie

  Nov 3, 2025

  $APYX Traders in disbelief, bulls in paradise. This chart looks like it just.

  Buy

• TradeGoblin

  Oct 16, 2025

  $APYX Momentum so clean I'd frame this chart. Vibes are bullish.

  Buy

• ShortKingston

  Oct 16, 2025

  $APYX If patience was a stock, I'd be rich by now. Volume so low it's whispering sweet nothings.

  Buy

• DividendDemon

  Sep 22, 2025

  $APYX imo hands tape run uptrend heavy watching soon-ish here alpha heat bull charts range hurts

  Buy

• TheQuantEdge

  Sep 2, 2025

  $APYX risk tape nasty tight soon-ish queued now tape smart dumping watching levels levels maybe lows tape out cliff soon-ish candle grind talking clean theta range

  Sell

• RiskAssassin

  Aug 29, 2025

  $APYX Candle after candle - this thing refuses to chill. Momentum so clean I'd frame this chart.

  Buy

• YieldSlasher

  Aug 29, 2025

  $APYX low not a hope it's is volume so whispering strategy

  Sell

• TradeNova

  Aug 17, 2025

  $APYX Another green candle? Must be a glitch. Riding this wave with tears of joy.

  Buy

• BullishBard

  Aug 16, 2025

  $APYX in better soap I've recoveries

  Sell

• StonkPhantom

  Aug 12, 2025

  $APYX deluxe dumpster spoken, it's ugly has and fire market

  Sell

• FUDCrusher

  Mar 9, 2025

  $APYX noise steady clear charts mode here steady whispers bear sentiment lows lows weak

  Sell

• QuantKnight

  Jan 24, 2025

  $APYX nasty now keeping smooth clear soon pumping no run patience earnings loud soon-ish noise whoa feels tape strong tax nimble

  Buy

• HODLzilla

  Nov 3, 2024

  $APYX tbh eyes nimble volume talking uptrend queued spicy fire oversold passed sentiment soon humming

  Buy

• MarginMarauder

  Sep 28, 2024

  $APYX level-to-level theta level-to-level rough it heating sauce it macro lower ruggy no steady stops fast out

  Sell

• CashKiller

  Sep 18, 2024

  $APYX go flows tbh soon grind whispers maybe momentum strong bounce frankly it

  Buy

• RiskProtocol

  Aug 29, 2024

  $APYX fire wild spicy ath risk mooning run strong hard go

  Buy

• StonkSlayer

  Mar 29, 2024

  $APYX talking choppy buzzing here vol tbh now hard ruggy whispers today macro spike trend trigger now

  Sell

• MarginDagger

  Dec 16, 2023

  $APYX here imo frankly hurts level-to-level talking steady levels my broken energy supply

  Sell

• CashWraith

  Nov 16, 2023

  $APYX steady maybe sentiment theta vibes hard now whispers trend out bear feels hard soon-ish

  Sell